Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
185 Camrelizumab monotherapy or combination therapy in patients with recurrent or metastatic cervical and endometrial carcinoma:a retrospective study
Compose a Response to This Article
Other responses
No responses have been published for this article.
